Indolequinone antitumor agents:: Correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity

被引:83
作者
Beall, HD
Winski, S
Swann, E
Hudnott, AR
Cotterill, AS
O'Sullivan, N
Green, SJ
Bien, R
Siegel, D
Ross, D
Moody, CJ
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Ctr Canc, Denver, CO 80262 USA
[3] Univ Exeter, Sch Chem, Exeter EX4 4QD, Devon, England
[4] Univ Loughborough, Dept Chem, Loughborough LE11 3TU, Leics, England
关键词
D O I
10.1021/jm980328r
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of indolequinones bearing various functional groups has been synthesized, and the effects of substituents on the metabolism of the quinones by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) were studied. Thus 5-methoxyindolequinones were prepared by the Nenitzescu reaction, followed by functional group interconversions. The methoxy group was subsequently displaced by amine nucleophiles to give a series of amine-substituted quinones. Metabolism of the quinones by NQO1 revealed that, in general, compounds with electron-withdrawing groups at the indole 3-position were among the best substrates, whereas those with amine groups at the 5-position were poor substrates. Compounds with a leaving group at the 3-indolyl methyl position generally inactivated the enzyme. The toxicity toward non-small-cell lung cancer cells with either high NQO1 activity (H460) or no detectable activity (H596) was also studied in representative quinones. Compounds which were good substrates for NQO1 showed the highest selectivity between the two cell lines.
引用
收藏
页码:4755 / 4766
页数:12
相关论文
共 37 条
  • [1] BARALDI PG, 1983, SYNTHESIS-STUTTGART, P902
  • [2] Indolequinone antitumor agents: Relationship between quinone structure and rate of metabolism by recombinant human NQO1
    Beall, HD
    Hudnott, AR
    Winski, S
    Siegel, D
    Swann, E
    Ross, D
    Moody, CJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (05) : 545 - 548
  • [3] BEALL HD, 1994, CANCER RES, V54, P3196
  • [4] BEALL HD, 1995, MOL PHARMACOL, V48, P499
  • [5] BEALL HD, 1997, P AM ASSOC CANC RES, V38, P6612
  • [6] DT-DIAPHORASE-CATALYZED REDUCTION OF 1,4-NAPHTHOQUINONE DERIVATIVES AND GLUTATHIONYL-QUINONE CONJUGATES
    BUFFINTON, GD
    OLLINGER, K
    BRUNMARK, A
    CADENAS, E
    [J]. BIOCHEMICAL JOURNAL, 1989, 257 (02) : 561 - 571
  • [7] THE ONE-ELECTRON REDUCTION POTENTIAL OF SEVERAL SUBSTRATES CAN BE RELATED TO THEIR REDUCTION RATES BY CYTOCHROME-P-450 REDUCTASE
    BUTLER, J
    HOEY, BM
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1161 (01) : 73 - 78
  • [8] ANAEROBIC REDUCTION OF NITROIMIDAZOLES BY REDUCED FLAVIN MONO-NUCLEOTIDE AND BY XANTHINE-OXIDASE
    CLARKE, ED
    WARDMAN, P
    GOULDING, KH
    [J]. BIOCHEMICAL PHARMACOLOGY, 1980, 29 (19) : 2684 - 2687
  • [9] NITROIMIDAZOLES AS ANAEROBIC ELECTRON-ACCEPTORS FOR XANTHINE-OXIDASE
    CLARKE, ED
    GOULDING, KH
    WARDMAN, P
    [J]. BIOCHEMICAL PHARMACOLOGY, 1982, 31 (20) : 3237 - 3242
  • [10] CYCLOPROPAMITOSENES, NOVEL BIOREDUCTIVE ANTICANCER AGENTS - SYNTHESIS, ELECTROCHEMISTRY, AND BIOLOGICAL-ACTIVITY OF 7-SUBSTITUTED CYCLOPROPAMITOSENES AND RELATED INDOLEQUINONES
    COTTERILL, AS
    MOODY, CJ
    MORTIMER, RJ
    NORTON, CL
    OSULLIVAN, N
    STEPHENS, MA
    STRADIOTTO, NR
    SWANN, E
    STRATFORD, IJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (22) : 3834 - 3843